The company said that it is pairing its diagnostics and life sciences businesses to support growth and focus on shared end markets and customers.

According to the DOJ, Osman Syed submitted more than $79 million in fraudulent claims to Medicare and Texas Medicaid for RPP testing.

Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.

NEW YORK – Startup company Amplified Sciences on Monday said it has raised $2.6 million in a Series Seed Preferred round. The round was led by Elevate Ventures and OCA Ventures with participation from ...

VANCOUVER, British Columbia — At the Association for Molecular Pathology annual meeting here this week, leadership briefed members on what to expect as the association's lawsuit challenging the US ...

Scientists in California and Michigan said that their FastGlioma algorithm can improve detection of tumor infiltration at the margins of surgery sites.

The company analyzes urine samples using a lateral flow test and optical reader combined with artificial intelligence to predict lung disease exacerbations.

NEW YORK – The Manchester University NHS Foundation Trust (MFT) said Thursday that it will use £1.4 million ($1.77 million) in UK government funding to support a two-year study across the UK of ...

While Congress has protected labs from PAMA cuts via a series of one-year delays, this has locked lab prices at 2016 levels, ...